$Tofacitinib Treatment of Refractory Cutaneous Leukocytoclastic Vasculitis: A Case Report$

Tofacitinib Treatment of Refractory Cutaneous Leukocytoclastic Vasculitis: A Case Report

IntroductionTo date, there is no treatment with proven efficacy for cutaneous leukocytoclastic vasculitis (CLV). Several reports have suggested that CLV responds favorably to corticosteroids, colchicine, nonsteroidal anti-inflammatory drugs (NSAIDs), azathioprine, and hydroxychloroquine (HCQ). To th...

Full description

Bibliographic Details
Main Authors:	Kai-Jun Zhu, Pei-Dan Yang, Qiang Xu
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-06-01
Series:	Frontiers in Immunology
Subjects:	cutaneous leukocytoclastic vasculitis tofacitinib JAK inhibitor case report inflammation
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2021.695768/full

Similar Items

An uncommon coexistence of sarcoidosis and cutaneous leukocytoclastic vasculitis in an adult
by: Birsen Ocakli, et al.
Published: (2019-01-01)

Cutaneous leukocytoclastic vasculitis associated with levofloxacin therapy
by: Dana Blyth, et al.
Published: (2012-01-01)

Tyrosine Kinase Inhibitors - Induced Cutaneous Leukocytoclastic Vasculitis
by: Diogo Alpuim Costa, et al.
Published: (2018-05-01)

Rare Association of Leukocytoclastic Vasculitis in Visceral Leishmaniaisis
by: Bharath A. Chhabria1*,, et al.
Published: (2019-01-01)

Impending central retinal vein occlusion in patient with idiopathic cutaneous leukocytoclastic vasculitis
by: Amir Akhavanrezayat, et al.
Published: (2020-12-01)

A Rare Case: Scabies-related Leukocytoclastic Vasculitis
by: Derya YAPAR, et al.
Published: (2020-09-01)

Methimazole-Induced Leukocytoclastic Vasculitis: A Case Report
by: Weeratian Tawanwongsri, et al.
Published: (2019-11-01)

Cutaneous leukocytoclastic vasculitis secondary to COVID‐19 infection: A case report
by: Fariba Iraji, et al.
Published: (2021-02-01)

Treatment of cutaneous sarcoidosis with tofacitinib 2% ointment and extra virgin olive oil
by: Mariam Alam, MD, et al.
Published: (2021-03-01)

Drug-induced leukocytoclastic vasculitis: tigecycline a rare cause
by: Kalpana Bhairavarasu, et al.
Published: (2015-01-01)

Warfarin-induced leukocytoclastic vasculitis and proteinuria
by: Khalid Jumean, et al.
Published: (2016-01-01)

Thalidomide-induced leukocytoclastic vasculitis in leprosy
by: Vasudha Abhijit Belgaumkar, et al.
Published: (2019-01-01)

Tenofovir-induced Leukocytoclastic Vasculitis
by: Said A. Al-Busafi, et al.
Published: (2017-09-01)

Leukocytoclastic Vasculitis as an Onset Symptom of Crohn’s Disease
by: Z. Tsiamoulos, et al.
Published: (2008-11-01)

Cutaneous leukocytoclastic vasculitis induced by continuous erythropoietin receptor activator
by: Hyeok-Jin Kwon, MD, et al.
Published: (2021-10-01)

Mycoplasmal upper respiratory infection presenting as leukocytoclastic vasculitis
by: Mana Rao, et al.
Published: (2015-02-01)

Mast Cells in Cutaneous Allergic Vasculitis: A Case Report
by: Hiroaki Inamura, et al.
Published: (2006-01-01)

Pazopanib-Induced Cutaneous Leukocytoclastic Vasculitis: An Exclusion Diagnosis of a Multidisciplinary Approach
by: Diogo Alpuim Costa, et al.
Published: (2017-11-01)

Atopic dermatitis: Tofacitinib, an option for refractory disease
by: Sineida Berbert Ferreira, et al.
Published: (2020-12-01)

Normocomplementemic urticarial vasculitis: An unusual presentation
by: Robin George Manappallil, et al.
Published: (2020-01-01)

Cytoplasmic Pattern Anti-neutrophil Cytoplasmic Antibody (cANCA)-positive Cutaneous Leukocytoclastic Vasculitis Induced by Propylthiouracil: A Case Report
by: Gulsah Elbuken, et al.
Published: (2016-06-01)

Tofacitinib in Hypertrophic Lichen Planus
by: Peter Seiringer, et al.
Published: (2020-07-01)

Leukocytoclastic vasculitis: An uncommon adverse effect of a common drug
by: Ankita Sheoran, et al.
Published: (2019-01-01)

Tofacitinib for refractory ocular mucous membrane pemphigoid
by: Hayley James, et al.
Published: (2021-06-01)

Treatment of cutaneous sarcoidosis with tofacitinib: A case report and review of evidence for Janus kinase inhibition in sarcoidosis
by: Ronan Talty, BS, et al.
Published: (2021-10-01)

Paraneoplastic leukocytoclastic vasculitis as an initial presentation of malignant pleural mesothelioma: a case report
by: Wong Shu, et al.
Published: (2012-08-01)

Indomethacin-Related Leukocytoclastic Vasculitis: A Case Report and Review of Literature
by: Nasir Hussain, et al.
Published: (2013-02-01)

Leukocytoclastic Vasculitis as an Extraintestinal Manifestation of Crohn’s Disease
by: Thiara Barcelos Rocha, et al.
Published: (2021-09-01)

Cutaneous necrotizing small‐vessel vasculitis induced by acute hepatitis E
by: Jean‐François Viallard, et al.
Published: (2019-08-01)

NEW APPROACHES TO PHARMACOTHERAPY OF RHEUMATOID ARTHRITIS: TOFACITINIB
by: E. L. Nasonov
Published: (2014-06-01)

Cutaneous Vasculitis with Gut Involvement During Secukinumab Treatment for Psoriatic Arthritis
by: Clara Chelli, et al.
Published: (2020-03-01)

Clinico-Pathological Analysis of Cutaneous Vasculitis
by: Mariam Nadeem Rana
Published: (2015-03-01)

Vasculitis of small and large vessels, a casual association?
by: Filipa Pedro, et al.

Leukocytoclastic Vasculitis of the Breast: A Case Report
by: Taeyang Ha, et al.
Published: (2018-04-01)

Efficacy and safety of tofacitinib for immune-mediated inflammatory rheumatic diseases (Part I)
by: E. L. Nasonov, et al.
Published: (2020-02-01)

Demographic characteristics, aetiology, and assessment of treatment options in leukocytoclastic vasculitis
by: Alkim Unal Cakiter, et al.
Published: (2017-04-01)

Leukocytoclastic Vasculitis after Long-Term Treatment with Sunitinib: A Case Report
by: Alexandra Karadimou, et al.
Published: (2011-08-01)

Cutaneous manifestations in Brucellosis
by: Zeynep Karaali, et al.
Published: (2011-01-01)

Acute hemorrhagic edema: Rare variety of leukocytoclastic vasculitis
by: Gaurav Ameta
Published: (2016-01-01)

Leukocytoclastic vasculitis in transplant recipients: A case series of 7 patients
by: Muneeb Ilyas, BSc, et al.
Published: (2017-07-01)